Equity strategies
Carmignac Portfolio Emergents
Share Class
LU1299303229
Risk Indicator
4 / 7
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
Cumulative Performance 10 YearsCumulative Performance 5 YearsCumulative Performance 3 YearsCumulative Performance 12 Months
From 19/11/2015
To 04/09/2025
+ 60.5 %
-
+ 18.8 %
+ 19.3 %
+ 14.7 %
Calendar Year Performance 2015Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023Calendar Year Performance 2024
- 4.1 %
+ 1.1 %
+ 18.9 %
- 18.8 %
+ 24.9 %
+ 43.8 %
- 10.9 %
- 14.8 %
+ 9.2 %
+ 4.8 %
Net Asset Value
160.48 €
Asset Under Management
427 M €
Net Equity Exposure31/07/2025
97.2 %
SFDR - Fund Classification
Article 9
Performance Overview
Find out about historical performance, volatility and all the performance measures that will enable you to assess the Fund's past performance.
Carmignac Portfolio Emergents fund performance
Fund performance vs. reference indicator (basis 100 - net of fees)
Data as of: Sep 6, 2025.Calendar Year Performance (as %)
Calendar Year Performance (as %)
Data as of: Aug 29, 2025.- Carmignac Portfolio Emergents - A EUR Acc
- Reference Indicator: MSCI EM NR index
| Carmignac Portfolio Emergents A EUR Acc | +9.4 % | +2.7 % | +7.0 % | +12.3 % | +16.1 % | +19.4 % | - |
| Reference Indicator | +5.3 % | -1.0 % | +6.2 % | +10.5 % | +16.9 % | +31.7 % | - |
| Category Average | +4.9 % | +3.7 % | +11.3 % | +9.4 % | +18.0 % | +28.8 % | - |
| Ranking (quartile) | 2 | 4 | 4 | 3 | 3 | 3 | - |
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
From 01/01/2013 the equity index reference indicators are calculated net dividends reinvested.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 29/08/2025.
Statistics (%)
These measures are used to assess a Fund's risk-adjusted performance. A well-performing Fund should ideally have a solid return (measured by the Sharpe ratio and alpha) relative to its risk (measured by volatility), while being well aligned with market expectations (measured by beta relative to the reference indicator).
Volatility
Data as of: Aug 29, 2025.| Fund | +16.8 % | +17.9 % | +17.1 % |
| Reference Indicator | +14.5 % | +15.0 % | +16.2 % |
Calculation : Weekly basis
Ratio
Data as of: Aug 29, 2025.| Sharpe Ratio | +0.1 % | +0.1 % | +0.2 % |
| Beta | +1.0 % | +1.0 % | +1.0 % |
| Alpha | 0.0 % | -0.1 % | 0.0 % |
Calculation : Weekly basis
Reference indicator: MSCI EM NR index
Source: Carmignac at Aug 29, 2025.
Monthly Gross Performance Contribution
The contribution to performance demonstrates the different sources of returns. The sum of these elements is equal to the performance before the deduction of management fees applicable to the portfolio for the period in question. Fees payable for the period account for the difference between the gross performance and the net performance.
Monthly Gross Performance Contribution
Data as of: Jul 31, 2025.Equity portfolio+1.4 %
Bond Portfolio0 %
Equity derivatives0.0 %
Bond derivatives0 %
Currency Derivatives0.0 %
Mutual fund0.0 %
Total+1.4 %
Performance scenarios
The figures shown include all the costs of the product itself, but may not include all the costs that you pay to your advisor or distributor. The figures do not take into account your personal tax situation, which may also affect how much you get back. What you will get from this product depends on future market performance. Market developments in the future are uncertain and cannot be accurately predicted. The unfavourable, moderate, and favourable scenarios shown are illustrations using the worst, average, and best performance of the product over the last 10 years. Markets could develop very differently in the future. This table shows the money you could get back over the next 5 years, under different scenarios, assuming that you invest 10 000 €.
Performance scenarios
Data as of: Jul 2025.Scenarios
If you exit after 1 year
If you exit after 5 years
Stress
What you might get back after costs
Average return each year
3680 €
-63.20 %
2940 €
-21.72 %
Unfavourable
What you might get back after costs
Average return each year
6940 €
-30.60 %
8420 €
-3.38 %
Moderate
What you might get back after costs
Average return each year
10120 €
+1.20 %
13090 €
+5.53 %
Favourable
What you might get back after costs
Average return each year
16980 €
+69.80 %
18690 €
+13.32 %
The unfavourable scenario occurred for an investment between 06/2021 and 07/2025.
The moderate scenario occurred for an investment between 08/2018 and 08/2023.
The favourable scenario occurred for an investment between 02/2016 and 02/2021.
Source: Carmignac at Jul 31, 2025.
Articles that may interest you
Emerging equities • July 25, 2025 • English
Carmignac Portfolio Emergents: Letter from the Fund Managers - Q2 2025
3 minute(s) read
Emerging equities • July 1, 2025 • English
Trump 2.0: Make Emerging Markets great again
5 minute(s) read
Emerging equities • April 17, 2025 • English
Carmignac Portfolio Emergents: Letter from the Fund Manager
4 minute(s) read
Did you enjoy the fund page?
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.